Concepedia

Author

Farhana Musarrat

Louisiana State University

Also Known As

, Farhana Musarrat

19

Publications

417

Citations

9

H-Index

26

Concepts

All Affiliations

Louisiana State UniversityUniversity of Louisiana at MonroeLouisiana State University Health Sciences Center New Orleans
FM

About

Farhana Musarrat is an author at Louisiana State University specializing in immunology, medicine, and viral immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

233

2

Immunology

4

4

233

3

Cell Biology

3

3

196

4

Pathology

2

2

195

5

Pharmacology

2

2

181

Farhana Musarrat

×

8

Publications

361

Citations

8

H-Index

YearCitations

The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

Farhana Musarrat, Vladimir N. Chouljenko, Achyut Dahal,

Journal of Medical Virology

2020

158

CTCF Binding Sites in the Herpes Simplex Virus 1 Genome Display Site-Specific CTCF Occupation, Protein Recruitment, and Insulator Function

Shannan D. Washington, Farhana Musarrat, Monica K. Ertel,

Journal of Virology

2018

48

The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K (gK) Is Required for gB Binding to Akt, Release of Intracellular Calcium, and Fusion of the Viral Envelope with Plasma Membranes

Farhana Musarrat, Nithya Jambunathan, Paul J. F. Rider,

Journal of Virology

2018

43

PEDF plus DHA modulate inflammation and stimulate nerve regeneration after HSV-1 infection

Jiucheng He, Donna M. Neumann, Azucena H Kakazu,

Experimental Eye Research

2017

37

Cellular and Viral Determinants of Herpes Simplex Virus 1 Entry and Intracellular Transport toward the Nuclei of Infected Cells

Farhana Musarrat, Vladimir N. Chouljenko, Konstantin G. Kousoulas

Journal of Virology

2021

25

The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections

Farhana Musarrat, Vladimir N. Chouljenko, Rafiq Nabi,

2020

23

Development of a reliable bovine neuronal cell culture system and labeled recombinant bovine herpesvirus type-1 for studying virus-host cell interactions

Jared S. Rudd, Farhana Musarrat, Konstantin G. Kousoulas

Virus Research

2020

15

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer

Rafiq Nabi, Farhana Musarrat, Jose Cesar Menk Pinto Lima,

Frontiers in Molecular Biosciences

2023

12

Page 1